US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Diffusion Pharmaceuticals Inc (DFFN)
Diffusion Pharmaceuticals Inc (DFFN) ニュース

DFFN

Diffusion Pharmaceuticals (DFFN)

Diffusion Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DFFN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/16	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/05/15	05 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/05/11	06 : 09	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/04/30	05 : 06	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/04/23	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/04/12	08 : 55	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/04/06	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/04/04	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/03/30	05 : 02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/03/28	21 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/03/19	05 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/03/07	06 : 05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/03/05	22 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/02/29	07 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/02/14	23 : 23	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/02/10	07 : 02	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/02/10	06 : 31	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/02/08	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/02/03	06 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/01/27	08 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/01/27	08 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/01/27	08 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/01/27	08 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/01/27	08 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/01/27	08 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/01/06	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/01/05	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2023/12/22	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2023/11/23	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2023/11/18	07 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:DFFN

1 2 3 4 5 6 7 8 9 10 次へ >>

BNP Paribas Easy MSCI US...

Grupo Fin Banorte (QX)

Hsbc Usa Inc Capped Dual...

Ark7 Properties Plus (GM)

BlackRock Institutional ...

Guangzhou Pharmaceutical (PK)

BNP Paribas Issuance BV

Lyxor Asset Management L...

RaiffeisenNachhaltigkeit...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約